A 78-year-old man with Lewy body dementia develops worsening agitation and visual hallucinations. A junior resident prescribes haloperidol 2 mg IM. Three hours later the patient develops severe rigidity, obtundation, and autonomic instability. The most likely explanation is:
- A The patient has developed neuroleptic malignant syndrome secondary to dopamine depletion in the basal ganglia
- B Haloperidol caused serotonin syndrome by blocking serotonin reuptake in Lewy body pathology
- C Lewy body dementia patients have extreme neuroleptic sensitivity; typical and even atypical antipsychotics can cause fatal reactions characterised by parkinsonism, sedation, and autonomic instability ✓
- D Anticholinergic toxicity from haloperidol crossed the blood-brain barrier in an elderly patient
Explanation
Lewy body dementia (DLB) patients have documented severe neuroleptic sensitivity — a hallmark feature of DLB — occurring in up to 50% of cases. Due to severe dopaminergic neuronal loss with alpha-synuclein Lewy bodies, even low-dose typical antipsychotics (haloperidol, chlorpromazine) and many atypicals can cause life-threatening reactions: irreversible parkinsonism, sedation, autonomic instability, and increased mortality. Quetiapine (low-dose) or clozapine are the preferred options if antipsychotics are absolutely necessary. This is not NMS (which requires fever as a cardinal feature).
Reference: Kaplan & Sadock's Synopsis of Psychiatry, 11th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.